Chunzhi Qin
Zhujing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ELAPOR1 suppresses tumor progression in colorectal cancer and indicates favorable prognosis.
Journal: Cancer biomarkers : section A of Disease markers
Published: June 19, 2023
Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-center, Randomized Controlled Trial.
Journal: Annals of surgery
Published: November 20, 2020
Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients.
Journal: Translational cancer research
Published: May 13, 2019
RANBP9 suppresses tumor proliferation in colorectal cancer.
Journal: Oncology letters
Published: August 08, 2018
CDKL1 promotes tumor proliferation and invasion in colorectal cancer.
Journal: OncoTargets and therapy
Published: March 30, 2017
Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer.
Journal: Annals of surgery
Published: October 15, 2015
Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases.
Journal: OncoTargets and therapy
Published: February 06, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026